Continuous Subcutaneous Insulin Infusion Market Size Worth $7.3 Billion By 2027

The global continuous subcutaneous insulin infusion market size is expected to reach USD 7.3 billion by 2027, registering a CAGR of 10.3% over the forecast period, according to a new report by Grand View Research, Inc. The key drivers of the market include increasing number of diabetes population coupled with technological advancement in the field of diabetes care.

According to International Diabetes Federation (IDF), the total number of diabetic population is expected to grow by 51.0% from 463.0 million in 2019 to 700.0 million in 2045. Rising health expenditure and growing awareness about preventive care is expected to boost market growth. According to the IDF, the estimated total global health expenditure to diabetes was USD 760.0 billion and is projected to grow to USD 845.0 billion by 2045. Furthermore, rising government initiatives to spread the awareness about diabetes is propelling the adoption of advanced diabetes management devices. Australian government launched Australian National Diabetes Strategy 2016 to 2020. The strategy aims to trace country’s national response to this epidemic and inform how existing limited healthcare can be better targeted across all level of government.

Increasing number of product launches and advent of artificial intelligence in the market is boosting the growth. Many startups are transforming CSII therapy. These companies are taking initiatives to lessen the burden of diabetes with help of AI technology. They are leveraging technological advancement to improve market solutions like integrated insulin pumps, non-invasive insulin delivery systems, and closed-loop artificial pancreases.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/continuous-subcutaneous-insulin-infusion-market

Further key findings from the study suggest:

  • North America accounted for the largest share in 2019 owing to favorable reimbursement policies, presence of key players, and frequent product launches
  • Asia Pacific is expected to see robust growth during the forecast period owing to presence of large diabetic population
  • By product, tethered pumps dominated the market owing to availability of products
  • By patient type, type 1 patients account for the largest share owing wide usage of insulin pumps
  • By end use, the hospitals segment dominated the market in 2019 and the homecare segment is expected to grow at a fastest pace
  • The market is highly competitive owing to continuous technological advancement and many innovative product launches.

Endotracheal Tubes Market Size Worth $2.9 Billion By 2027

The global endotracheal tubes market size is expected to reach USD 2.9 billion by 2027, expanding at a CAGR of 6.0%, according to a new report by Grand View Research, Inc. The rising prevalence of chronic diseases such as respiratory, cardiovascular diseases, and increasing number of surgical procedures, are expected to propel market growth. In addition, technological development in the medical device is further expected to contribute to market growth during forecast period. Recently Medtronic has launched a Shiley laser oral endotracheal tubes that are most widely used for ventilation during CO2 and KTP laser surgeries of the laryngeal or tracheal area.

Moreover, growing need for ventilator associated with pneumonia and increasing geriatric population that are prone to chronic diseases is one of the important factors responsible for market growth during assessment period. As per World Health Organization Report 2019, 4.0 million people die prematurely due to chronic respiratory disease. Due to increasing air pollution the prevalence of respiratory diseases is also increasing. According to World Health Organization Report 2019, around 2.0 billion people are exposed to indoor toxic, 1.0 billion people are exposed to outdoor pollutant air, and around 1.0 billion people are exposed to tobacco smoke. Above factors are likely to boost market growth. In addition, increasing awareness about technologically advanced medical devices, and developments in the field of nano biotechnology and drug design are some of the factors responsible for market growth.

North America accounted for the highest market share in 2019 owing to the advanced healthcare system and the growing prevalence of chronic diseases in the country. In addition, the presence of major players in the region contributed to market growth.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/endotracheal-tubes-market

Further Key Findings From the Report Suggest:

  • By product type, the regular endotracheal tube segment held the largest market share of 32% in 2019 owing to increasing prevalence of respiratory diseases
  • Orotracheal segment held the largest market share accounted for 64% in 2019 owing to its high applicability, increased usage and comfortability
  • North America dominated the market in 2019. Rising prevalence of chronic respiratory disease is one of the major factors driving the market growth in this region
  • Asia Pacific is expected to witness the fastest growth over the forecast period. As the healthcare infrastructure in the region is developing resulting in increased number of surgeries being performed and eventually fueling the growth of the market.

Neonatal Critical Care Equipment Market Worth $1.3 Billion By 2027

The global neonatal critical care equipment market size is expected to reach USD 1.3 billion in 2027, expanding at a CAGR of 9.4%, according to a new report by Grand View Research, Inc. High number of preterm births, prevalence of neonatal jaundice, and innovative product launches are some of the factors responsible for market growth. The Neonatal Intensive Care Unit (NICU) provides treatment to premature infants and those having breathing problems, anemia, heart defects, and other problems requiring critical care.

The majority of admissions in the NICU comprise of the premature/preterm babies. To support their treatment, various organizations are providing financial assistance to healthcare providers. For instance, in October 2018, the Australian Government announced a provision of AUD 600,000 to the Miracle Babies Foundation to support the families of premature babies. The overall assessment of the market reveals that the number of cases of jaundice and respiratory problems in neonates is increasing and precautionary measures are being taken by government authorities. For instance, governments are increasing the number of NICU facilities in order to tackle health related problems in neonates.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/neonatal-critical-care-equipment-market

Further Key Findings from the Study Suggest:

  • The Respiratory equipment segment dominated the market in terms of revenue share in 2019 due to the high prevalence of respiratory disorders among the newborn babies
  • North America dominated the market in terms of revenue share in 2019 due to high healthcare expenditure and measures adopted by organizations to improve healthcare for neonatal
  • BC Children’s Hospital, Vancouver, announced to launch Teck Acute Care Centre and claimed to have North America’s first NICU to provide care to mother and infant in the same room
  • On the other hand, Asia Pacific is likely to exhibit the fastest CAGR of 10.9% from 2020 to 2027 pertaining to a high birth rate in the region
  • The manufacturers of neonatal critical care equipment are undertaking research and development activities to provide innovative products, in order to cater to the increasing demand for NICUs globally
  • In January 2016, Maquet Medical Systems USA (Getinge Group) launched two ventilators for use in NICU, the Servo-U and Servo-n.

Polycystic Ovarian Syndrome Treatment Market Worth $5.1 Billion By 2025

The global polycystic ovarian syndrome treatment market is expected to reach USD 5.1 billion by 2025, according to a new report by Grand View Research, Inc. According to the Centers of Disease Control & Prevention (CDC), Polycystic Ovary Syndrome (PCOS) is the most common cause of female infertility. Approximately 6% to 12% women of reproductive age suffer from PCOS in the U. S. Moreover, progression of this condition can lead to metabolic abnormalities, which may result in development of type 2 diabetes, if the syndrome is not treated on time. The severity of the disorder increases the risk of developing uterine and endometrial cancers in patients. Thus, early diagnosis and effective treatment are significant for successful recovery. 

Presently, no specific drug is commercially available for this condition. Thus, treating symptoms is the prime aim of the treatment regimen. Owing to the various symptoms associated with this syndrome, a range of drug class/combinations is used in the treatment. Therefore, market leaders are focusing on developing a specific drug/treatment to cure the root cause of this disease. AstraZeneca is one of the leaders involved in developing such a drug.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/polycystic-ovarian-syndrome-pcos-treatment-market

Further Key Findings from the Study Suggest:

  • Constantly rising prevalence of PCOS is primarily driving the growth of this market across the globe
  • Initiatives undertaken by government bodies and market players to create awareness about benefits of early diagnosis and commercially available treatment for PCOS among women is boosting the market
  • Treatment of PCOS mainly includes lifestyle modification through balanced diet, exercise, and drugs such as oral contraceptives, antiandrogens, insulin-sensitizing agents, anti-obesity agents, and antidepressants
  • Surgical procedures such as ovarian wedge resection and laparoscopic ovarian drilling are preferred when patients do not respond to drug therapy
  • Insulin-sensitizing agents segment is dominating the market since these drugs are widely used for treatment of insulin resistance to prevent diabetes, which is a risk associated with PCOS
  • Oral Contraceptive Pills (OCPs) segment is expected to grow at the fastest rate followed by antiandrogen agents that are used for treating symptomatic conditions such as hirsutism and acne
  • North America is dominating the market followed by Europe. High awareness and availability of advanced healthcare facilities are factors responsible for the dominant share held by this region
  • Asia Pacific is expected to be the fastest growing region over the forecast period.Increasing government initiatives for raising awareness about symptoms & diagnosis of PCOS and available treatment are increasing the number of women being diagnosed with this syndrome in the region
  • China is one of the most lucrative markets with tremendous growth opportunities for global as well as local players owing to presence of a large pool of obese female population, which is at high risk of PCOS
  • Key players in the market include AstraZeneca, Bayer AG, Merck KGaA, Abbott, Sanofi, Pfizer, Inc., Bristol-Myer Squibb Company, and Novartis AG. The market also includes other emerging players such as Teva Pharmaceutical Industries Limited and Ferring Pharmaceuticals, Inc., which are expected to grow significantly in the near future.

FISH Imaging Systems Market Worth $1.4 Billion By 2025

The global fluorescence in situ hybridization imaging systems market size is expected to reach USD 1.4 billion by 2025, at a CAGR of 8.1% according to a new report by Grand View Research, Inc. Increasing R&D investments pertaining to in vitro diagnostics are expected to drive the Fluorescence In Situ Hybridization (FISH) imaging systems market. The presence of government organizations, such as the European Diagnostic Manufacturers Association that focuses on the development and growth of the in vitro diagnostics market in Europe, is also contributing to growth.

Furthermore, FISH imaging systems are gaining popularity in diagnostics for the determination of suspected diseases caused by pathogens or bacteria. Increasing incidence of genetic diseases, such as lymphoma, solid tumors, leukemia, autism, and other developmental syndromes, is also expected to boost adoption. Growing penetration of fluoroscopy, microscopes, illuminators, and CCD cameras in testing for infectious diseases is expanding growth opportunities for these systems. Increasing prevalence of diseases with chromosomal aberrations, such as cancer and genetic abnormalities, as well as unmet diagnostic & clinical needs in developing countries, is anticipated to drive the market.

Moreover, increasing demand for rapid, sensitive, & accurate diagnostic techniques for validation of diseases, coupled with rising awareness, increase in healthcare expenditure, and extensive R&D for the development of novel imaging systems are also expected to drive growth over the forecast period.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/fluorescence-in-situ-hybridization-fish-imaging-systems-market

Further Key Findings From the Report Suggest:

  • Instruments held the largest market, whereas FISH imaging services are expected to grow at the fastest rate during the forecast period
  • At present, the market penetration of FISH imaging in cancer diagnostics is very high, hence the diagnostic laboratories segment accounted for larger revenues
  • Cancer diagnosis held the largest revenue share owing to increasing incidence of cancer, thus fueling the adoption of FISH imaging systems
  • Among end-use segments, companion diagnostics is expected to witness faster growth than research and diagnostic segments
  • Diagnostic laboratories held the dominant position in 2016 as these systems are predominantly used in various clinical studies for visualization of precancerous lesions in cervical cancer, assessing the risk of human papillomavirus, and for detection of leukemia, myelodysplastic syndrome, multiple myeloma, & chromosomal abnormalities
  • North America held the largest revenue share owing to extensive adoption of these solutions in research and development across this region
  • Asia Pacific is anticipated to exhibit lucrative CAGR over the forecast period due to the increase in investments by manufacturers & governments, supportive government initiatives in the biotechnology sector, and the presence of a large number of untapped opportunities
  • The industry is highly competitive with a limited number of players holding a majority of the overall revenues. Some of the most notable market participants are Thermo Fisher Scientific, Inc., and General Electric Company. They account for a considerable share of the industry

Europe Building-integrated Photovoltaics Market Size Worth $20.4 Billion By 2027

The Europe building-integrated photovoltaics market size is expected to reach USD 20.4 billion by 2027, expanding at a 27.2% CAGR during the forecast period, according to a new report by Grand View Research, Inc. Rising demand for crystalline silicon (C Si) based Building-integrated Photovoltaics (BIPV) generated the premier revenue share on account of the high strength of the product.

Increasing demand for facade integration stems from the growth of building and construction industry, primarily in the developing economies in European region. The introduction of ventilated photovoltaic facades provides superior benefits such as greater yield in low irradiation and high temperature conditions, reduction of acoustic pollution, elimination of thermal barriers, and superior insulation performance.

The demand for building-integrated photovoltaics in Europe is anticipated to grow on account of the rising demand for aesthetically appealing solar energy-harnessing systems. According to a report published in Netherlands titled The Relative Importance of Aesthetics in the Adoption Process of Solar Panels in the Netherlands, aesthetic value of a solar panel is the greatest variable for 40% of buyers once the price is in a reasonable range. Hence, consumer preference towards BIPV products having good aesthetic value is gaining momentum which is anticipated to drive the market for black colored panels in the region during the forecast period.

Germany is one of the top country level market for the Europe accounting for 25.11% of the market share in 2019. The demand for building-integrated photovoltaics in roofs accounted for the highest market share driven by ease of product installation. BIPVs can be installed easily in the building roofs post-construction of the building as it requires minimal renovations. Besides, the segment has realized high technological advancements, which is expected to result in a decline in the overall installation costs leading to market growth over the forecast period.

Rising concerns regarding environmental pollution caused using non-renewable sources of energy are anticipated to drive the Europe BIPV market over the forecast period. The demand for the integration of photovoltaics stems from the superior aesthetic properties they impart. Building-integrated photovoltaics can replace regular roofs, windows, and building walls without compromising the aesthetics of the building, thereby leading to an increased adoption.

The presence of significant industry participants such as AGC Inc.; Canadian Solar; UAB GLASSBEL BALTIC; Onyx Solar Group Inc.; BiPVco; ISSOL sa; Heliatek GmBH; Polysolar; Flisom; ertex solartechnik GmbH; and Hanergy Mobile Energy Holding Group Limited will further aid market penetration.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/europe-building-integrated-photovoltaics-market

Further key findings from the study suggest:

  • The Italy building-integrated photovoltaics market revenue was valued over USD 613.8 million in 2019 and is projected to register a CAGR of over 29% over the projected period
  • Roofs-mount photovoltaics held the largest market share of over 39% in terms of revenue in 2019
  • Improved aesthetic appeal due to its transparent nature along with significant technological advancements in glass integrated installations is expected to drive the glass segment over the forecast period
  • Residential segment led the market due to efforts made by end users to limit their reliance on conventional sources and increase their adoption of greener sources of power generation
  • Spain is expected to witness the highest CAGR of 30.9% over the forecast period
  • Some of the major market players are AGC Solar, BIPV Ltd., Belectric Holding GmbH, and Heliatek GmbH. The companies are utilizing merger and acquisition strategy to enhance their global reach

Interdental Cleaning Products Market Size Worth $1.3 Billion By 2025

The global interdental cleaning products market size is anticipated to reach USD 1.3 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a CAGR of 4.6% over the forecast period. Increasing prevalence of dental cavity and rising awareness related to dental hygiene are expected to drive the market. Increase indental problems like plaque and bad breath is fueling the demand for interdental cleaning products.

Increasing dental problems like cavities and inflammation of the gums is one of the reasons for the growth of the market. For instance, around 35 to 45 percent of the tooth surfaces is found to have interdental spaces. More than 500 bacterial species are found to be in plaque, which may lead to bad breath. Owing to improper dental care, the plaque are build up on the gum line and below the teeth that may cause many dental problems. In order to get rid of these problems, many innovative techniques are used like electrical brushes and dental tapes. This may lead to the market growth in the upcoming years.

A flexible interdental brush helps to get rid of the problems in between the teeth where a regular brush cannot reach. Major players are taking many initiatives to spread awareness related to dental hygiene and good breath. There are new innovative product launches that may boost the market growth in upcoming years. For instance, in 2019, TePe’s Interdental Brushes was awarded as the best product in the global market and it is mainly used in U.K. with over more than 10000 shoppers voting it to be the best product.

The interdental brushes segment is expected to witness the fastest growth over the forecast period. This is mainly due to advancement in technology such as battery powered and electric interdental cleaning brushes. These help in complete mouth cleaning and removing the food particles.

Europe is emerged as the largest market in 2018 and is expected to witness significant growth over the forecast period. Increasing prevalence of oral problems mainly in the western part of Europe are the regions for the growth of the market. Asia Pacific is anticipated to be the fastest growing regional market over the forecast period due to growing population. For instance, in February 2019, Philips announced to launch new products in interdental cleaning as Phillips India is the largest market in India for such products.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/interdental-cleaning-products-market

Further key findings from the study suggest:

  • By product, interdental brushes are anticipated to ascend at a CAGR of 5.3% over the forecast period. Toothpicks dominated the market with a share of 43.1% in 2018
  • The offline channel generated a revenue of USD 857.4 million in 2018. The online channel is expected to expand at the fastest CAGR of 7.0% over the forecast period due to internet penetration and online shopping
  • Asia Pacific is the fastest growing regional market, wherein India holds the largest share of the interdental brushes segment
  • Europe dominated the global interdental cleaning products market in 2018 and accounted for 29.3% share of the overall revenue. This trend is projected to continue over the next few years
  • The industry is highly competitive with the leading players including TePe Plackers, Trisa AG, Lion, GUM, Dentalpro, E-Clean, Den Tek, Colgate, Yawaraka, Curaprox, M+C Schiffer GmbH, Naisen Caring, and INHAN
  • Various manufacturers are concentrating on new product launches, capacity expansion, and technological innovation to estimate existing and future demand patterns from upcoming product segments.

Coffee Beauty Products Market Size Worth $835.5 Million By 2025

The global coffee beauty products market size is expected to reach USD 835.5 million by 2025, expanding at a CAGR of 5.1% from 2019 to 2025, according to a new report by Grand View Research, Inc. Growing awareness about harmful impacts of synthetic chemicals and prominent inclination towards natural ingredient based beauty solutions has been driving the market. In addition to this, rising awareness about caffeine benefits such as enhanced blood circulation for skin and presence of antioxidant and anti-aging effects is expected to drive the market.

Companies are focusing on manufacturing coffee beauty solutions, thereby catering to consumers who are seeking natural based products. For instance, MCaffeine, India’s first caffeinated personal care brand, offers a wide range of coffee infused products such as face scrubs, body butter, body scrub, and face masks to provide the customers with benefits of coffee ingredients. Mr. Bean Body Care also provides coffee scrub in different flavors such as coconut, coco berry, Manuka honey, peppermint, along with body balms, which help in reducing the appearance of stretch marks, varicose veins, and age spots.

Skin care held the largest share of 34.5% in 2018. People are more concerned about their aging skin, which is driving them to use more of coffee beauty products than others, which, in turn, is expected to contribute to its demand. For instance, Mr Bean Body Care provides coffee mocha mud masks that help in cleansing skin and minimize the pore size, which is grounded with coffee beans, macadamia oil, and kaolin clay.

Hair care is expected to expand at a CAGR of 5.8% over the forecast period. Benefits such as improvement and strengthening of hair texture, enhanced blood circulation in scalp, and prevention from hair loss are some of the factors expected to impact the demand for the segment.

Online mode of distribution is an emerging mode of a channel, expanding at a CAGR of 5.6% over the forecast period. Availability of a wide range of products from premium as well as international brands is also one of the key factors expected to drive the acceptance of online purchase. Moreover, luxury brands such as The Body Shop have their own online channels apart from physical stores to make access easier for the consumers.

Asia Pacific is expected to register a CAGR of 5.8% over the forecast period. Adoption of western culture and inclination towards the trends of European countries for the usage of caffeine in beauty products are driving the market in the region. French brand, Terre De Mars is all set to launch its luxury coffee based face scrub and body scrubs soon for millennials.

Key players in the market include L’Oréal Paris; Avon Product Inc.; Bio care; Mr. Bean Body Care; The Body Shop; Java Skin Care; Estee Lauder Inc.; The Beauty Company; OGX; and MCaffeine. Demand for coffee beauty products that are free from harsh chemicals has been growing over the past few years. Major market players have been significantly contributing into research and development to make more of these products available according to the needs of the consumers.

Various market players are involved in manufacturing a variety of coffee beauty products such as body scrubs, masks, shampoos, perfumes, and lip care. Companies namely Loreal Paris, Java Skin care, and Estee Lauder launch lip glosses, lipsticks, and body and face scrubs made of coffee beauty products.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/coffee-beauty-products-market

Further key findings from the study suggest:

  • Skin care dominated the global market with a share of 34.5% in 2018
  • Europe dominated the market in 2018. This trend is projected to continue over the next few years owing to growing demand for hair care products
  • Asia Pacific is expected to witness high demand over the forecast period due to increasing exposure and demand for coffee beauty products
  • coffee beauty products market is highly competitive in nature with the main players including Estee Lauder, Body Bean Care, The Body Shop, and L’Oréal Paris
  • Various manufacturers are concentrating on new product launches and capacity expansion to estimate existing and future demand patterns from upcoming product segments.

U.S. Hotels, Resorts & Cruise Lines Market Worth $299.3 Billion By 2025

The U.S. hotels, resorts & cruise lines market is expected to reach USD 299.3 billion by 2025, according to a new report by Grand View Research, Inc. As travel and tourism keep on growing every year, hotel and cruise line industry are recognized as an ever-blooming business. High competition is observed amongst the companies due to soaring demand for accommodation. This, in turn, is anticipated to boost the revenue inflow in this market.

Currently, majority of the population are tech-savvy and are comfortable using mobile apps and websites. Customers prefer to plan their trips and search for hotel options all via a digital interface. As a result, hotels are engaged in offerings up-to-date and user-friendly services such as online bookings, cancellation, and payment mode. This, in turn, is expected to enable company in reinforcing their presence in the space.

Effective usage of digital marketing & social media promotions is recognized as the high driving force for the market. This is mainly because it allows maintaining harmony and synergy between companies and customers, thereby driving booking rates. Moreover, usage of public forum like Yelp helps in understanding the customer’s’ expectation which further helps in devising the investment plans as per the customer’s need.

However, alternate accommodation such as Airbnb and security challenges associated with this industry is expected to slow down the market throughout the forecast period.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/us-hotels-resorts-cruise-lines-market

Further Key Findings From the Report Suggest:

  • Hotel & motel dominated the market in 2016 with respect to revenue generation
  • Presence of a substantial number of international hotels in the U.S. has contributed to the largest share of this segment
  • In the crowded tourist or travel spots, it is easy to spot hotels in every locality
  • Cruise lines is the fastest growing segment
  • Understanding the growth potential of cruising travel, the cruise line industry is committed to add new capacity in its lines
  • The cruise lines are continuously putting efforts for improving its “cheap and fun vacation deals”
  • These factors are expected to lucratively enhance the segment growth throughout the forecast period
  • Some major hotel companies that are operating in the space are Hyatt Corporation, MARRIOTT INTERNATIONAL, INC.; and Hilton
  • Royal Caribbean International and Carnival Corporation & plc are some prominent cruise line in the market
  • These companies are observed to make significant investment to boost their service portfolio and meet the customers’ expectations

Biopharmaceuticals Manufacturing Consumables Testing Market Worth $709.92 Million By 2025

The global biopharmaceuticals manufacturing consumables testing market size is expected to reach USD 709.92 million by 2025 at a 12.1% CAGR, according to a new report by Grand View Research, Inc. The market is driven by the growing need for an in-depth assessment of raw materials for the successful and rapid launch of the final product. Rising awareness pertaining to internal standards as well as external regulations in the biopharmaceutical industry is also aiding the market growth.

In the past few years, there has been a major paradigm shift from small chemical molecules to large biological molecules. As a result, the biopharmaceutical industry is geared toward exploring every aspect involved in the manufacturing process.

Regulatory and quality expectations for best quality raw materials and intermediates continue to increase. This, in turn, has pressurized vendors engaged in the manufacturing of excipients and raw materials to invest in standardizing functionality as well as establishing sophisticated processes to consistently address the needs of final product developers.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/biopharmaceuticals-manufacturing-consumables-testing-market

Further key findings from the study suggest:

  • Based on service, compendial and multi-compendial testing held the largest share owing to demand from various manufacturers for raw materials that are compliant to regulatory standards
  • Testing services for Active Pharmaceutical Ingredients (APIs) accounted for the largest revenue share owing to the presence of a wide range of services in this segment
  • Presence of a large number of biologics manufacturing entities in the U.S. has resulted in North America dominating the global market in 2017. Rising competitive rivalry amongst market participants is also attributive for the large share of this region
  • Asia Pacific is expected to emerge as the fastest-growing regional market, fueled primarily by expansion of the contract service industry in several Asian countries. This is partly attributed to low operating costs in these nations
  • Key service providers in the market include Eurofins Scientific; Merck KGaA; Charles River; Agilent Technologies; and Catalent, Inc. These service providers are engaged in contract partnerships with major biopharmaceutical manufacturing companies.